B. Riley Wealth Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,008
Closed -$801K 1437
2021
Q4
$801K Sell
8,008
-7,776
-49% -$804K 0.02% 604
2021
Q3
$1.97M Buy
15,784
+1,580
+11% +$188K 0.06% 333
2021
Q2
$1.82M Buy
14,204
+5,315
+60% +$715K 0.06% 360
2021
Q1
$1.32M Buy
8,889
+1,851
+26% +$280K 0.05% 411
2020
Q4
$909K Buy
7,038
+1,193
+20% +$137K 0.05% 358
2020
Q3
$616K Sell
5,845
-715
-11% -$65.4K 0.03% 461
2020
Q2
$533K Buy
+6,560
New +$529K 0.04% 440

Other funds holding GH

B. Riley Wealth Advisors's GH Position: Q1 2022 in Review

B. Riley Wealth Advisors sold out of Guardant Health (GH) in Q1 2022, closing a stake of 8,008 shares — an estimated $801K sold.

B. Riley Wealth Advisors first reported a position in GH in Q2 2020 and held it in 7 quarters. The position peaked at $1.97M in Q3 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • B. Riley Wealth Advisors reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 8,008 Guardant Health shares in Q1 2022, an estimated $801K.
  • B. Riley Wealth Advisors first reported a position in Guardant Health in Q2 2020 and held it in 7 quarters.
  • B. Riley Wealth Advisors's Guardant Health position peaked at $1.97M in Q3 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2022, filed 2 May 2022.